Cover Image

Polycystic kidney disease in children: the current status and the next horizon

Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) are inherited disorders that share many features such as kidney cysts, hypertension, urinary concentrating defects, and progressive chronic kidney disease. The underlying pathogenic mechani...

Full description

Saved in:
Bibliographic Details
Main Authors: Cadnapaphornchai, Melissa (Author) , Dell, Katherine M. (Author) , Gimpel, Charlotte (Author) , Guay-Woodford, Lisa M. (Author) , Gulati, Ashima (Author) , Hartung, Erum A. (Author) , Liebau, Max C. (Author) , Mallett, Andrew J. (Author) , Marlais, Matko (Author) , Mekahli, Djalila (Author) , Piccirilli, Alixandra (Author) , Seeman, Tomas (Author) , Tindal, Kristin (Author) , Winyard, Paul J. D. (Author)
Format: Article (Journal)
Language:English
Published: September 2025
In: American journal of kidney diseases
Year: 2025, Volume: 86, Issue: 3, Pages: 383-392
ISSN:1523-6838
DOI:10.1053/j.ajkd.2025.01.022
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1053/j.ajkd.2025.01.022
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0272638625007723
Get full text
Author Notes:Melissa A. Cadnapaphornchai, Katherine M. Dell, Charlotte Gimpel, Lisa M. Guay-Woodford, Ashima Gulati, Erum A. Hartung, Max C. Liebau, Andrew J. Mallett, Matko Marlais, Djalila Mekahli, Alixandra Piccirilli, Tomas Seeman, Kristin Tindal, and Paul J.D. Winyard
Description
Summary:Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) are inherited disorders that share many features such as kidney cysts, hypertension, urinary concentrating defects, and progressive chronic kidney disease. The underlying pathogenic mechanisms for both include cilia dysfunction and dysregulated intracellular signaling. ADPKD has been traditionally regarded as an adult-onset disease whereas ARPKD has been classically described as an infantile or childhood condition. However, clinicians must recognize that both disorders can present across all age groups, ranging from fetal life and infancy to childhood and adolescence as well as adulthood. Here we highlight the points of overlap and distinct features for these disorders with respect to pathogenesis, diagnostic modalities (radiological and genetic), clinical assessment, and early therapeutic management. In particular, we consider key issues at 2 critical points for transition of care: fetal life to infancy and adolescence to adulthood. These time points are poorly covered in the extant literature. Therefore, we recommend guiding principles for transitions of clinical care at these critical junctures in the life span. Although there is no cure for polycystic kidney disease (PKD), recent insights into pathogenic mechanisms have identified promising therapeutic targets that are currently being evaluated in a growing portfolio of clinical trials. We summarize the key findings from these largely adult-based trials and discuss the implications for designing child-focused studies. Finally, we look forward to the next horizon for childhood PKD, highlighting gaps in our current knowledge and discussing future directions and strategies to attenuate the full burden of disease for children affected with PKD.
Item Description:Online verfügbar: 18. März 2025, Artikelversion: 20. August 2025
Gesehen am 20.03.2026
Physical Description:Online Resource
ISSN:1523-6838
DOI:10.1053/j.ajkd.2025.01.022

Similar Items